
Rapid Relief: Common Pill Offers Quick Cure for Covid-related Smell Loss
Clinical trial data suggests that the antiviral pill ensitrelvir can shorten the duration of loss of smell and taste caused by COVID-19. Unlike other COVID-19 treatments, ensitrelvir is not limited to high-risk individuals and is available to those with mild to moderate symptoms. The drug has shown promising results in reducing smell and taste loss symptoms, with the percentage of participants reporting these symptoms significantly lower in the ensitrelvir groups compared to the placebo group. Ensitrelvir's developer, Shionogi, is continuing clinical trials, and the drug has not yet been approved outside of Japan.
